Labor is the single biggest line item for many hospital and health system budgets. As baby boomers retire and begin to face age-related health issues, they will likely seek more services from hospitals. But as the patient population expands, the pool of nurses and other caregivers is expected to recede, which—all else being equal—might push hospital labor costs even higher.Read more
Filter by category or month:
Life sciences companies are usually not considered market leaders in the race to embrace new technology and digital transformation. Whether deserved or not, this reputation—and the reality—should change. Without the advantages of digital, leaders in life sciences could lose competitive ground that can’t easily be regained.
It’s an urgent call to action, but also a huge opportunity.Read more
Rachel’s end-to-end digital hospital experience
Imagine it’s a few years in the future; say, 2025. Four-year-old Rachel’s hospital operates under an incentive reimbursement model driven by quality and care outcomes for the populations it serves. Because Rachel has a history of medical complications that places her within the hospital’s higher-risk populations that require close monitoring,
Inc. magazine released its 11th annual 30 Under 30 list featuring young entrepreneurs working to solve some of the world’s biggest challenges. The founders of Neopenda made the list – the startup makes wearables that monitor four newborn vitals in developing countries. The women who founded Neopenda, which launched in 2015,Read more
To improve health care, it often makes sense to invest in innovations that build upon existing technologies and new approaches that address the many health conditions for which there are no effective treatments. Innovations that reduce costs and morbidity are especially welcome.
While engineers and scientists continue to develop new technologies, they can run into barriers when building a case for their innovations,Read more
After years of engaging primarily with physicians, many pharmaceutical companies are making a significant shift by starting to focus their commercial activities on building relationships directly with patients. Companies with highly specialized and rare disease therapies often have had this focus longer. But now many companies, including those with diversified portfolios, are looking for ways to add value along the continuum of patient care.Read more